Different Catechol-O-Methyl Transferase Inhibitors in Parkinson's Disease: A Bayesian Network Meta-Analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Different Catechol-O-Methyl Transferase Inhibitors in Parkinson's Disease: A Bayesian Network Meta-Analysis
Authors
Keywords
-
Journal
Frontiers in Neurology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-09-25
DOI
10.3389/fneur.2021.707723
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Randomized, Controlled Study of Opicapone in Japanese Parkinson's Patients With Motor Fluctuations
- (2020) Atsushi Takeda et al. MOVEMENT DISORDERS
- Parkinson's Disease and Parkinsonism
- (2019) Michael T Hayes AMERICAN JOURNAL OF MEDICINE
- International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson's disease
- (2018) Susan H. Fox et al. MOVEMENT DISORDERS
- Effectiveness of opicapone and switching from entacapone in fluctuating Parkinson disease
- (2018) Joaquim J. Ferreira et al. NEUROLOGY
- Opicapone for the treatment of Parkinson's disease: A review of a new licensed medicine
- (2018) Margherita Fabbri et al. MOVEMENT DISORDERS
- Inhibitors of MAO-B and COMT: their effects on brain dopamine levels and uses in Parkinson’s disease
- (2018) John P. M. Finberg JOURNAL OF NEURAL TRANSMISSION
- Opicapone for the management of end-of-dose motor fluctuations in patients with Parkinson’s disease treated with L-DOPA
- (2017) Andrew J. Lees et al. Expert Review of Neurotherapeutics
- Opicapone for the management of end-of-dose motor fluctuations in patients with Parkinson’s disease treated with L-DOPA
- (2017) Andrew J. Lees et al. Expert Review of Neurotherapeutics
- Opicapone as Adjunct to Levodopa Therapy in Patients With Parkinson Disease and Motor Fluctuations
- (2017) Andrew J. Lees et al. JAMA Neurology
- Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial
- (2016) Joaquim J Ferreira et al. LANCET NEUROLOGY
- The epidemiology of Parkinson's disease: risk factors and prevention
- (2016) Alberto Ascherio et al. LANCET NEUROLOGY
- Novel formulations and modes of delivery of levodopa
- (2014) Werner Poewe et al. MOVEMENT DISORDERS
- The factor structure of the UPDRS motor scores changes during early Parkinson's disease
- (2014) Brage Brakedal et al. PARKINSONISM & RELATED DISORDERS
- Perampanel in Parkinson Disease Fluctuations
- (2012) Olivier Rascol et al. CLINICAL NEUROPHARMACOLOGY
- Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression
- (2012) Ian R. White et al. Research Synthesis Methods
- Automating network meta-analysis
- (2012) Gert van Valkenhoef et al. Research Synthesis Methods
- A Double-Blind, Randomized, Placebo and Active-Controlled Study of Nebicapone for the Treatment of Motor Fluctuations in Parkinson's Disease
- (2010) Joaquim J. Ferreira et al. CNS Neuroscience & Therapeutics
- Progression of Parkinson's disease in the clinical phase: potential markers
- (2009) Walter Maetzler et al. LANCET NEUROLOGY
- Treatments for Parkinson disease--past achievements and current clinical needs
- (2009) W. Poewe NEUROLOGY
- Parkinson's disease: clinical features and diagnosis
- (2008) J Jankovic JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started